References and Notes
1
Len C.
Mackenzie G.
Tetrahedron
2006,
62:
9085
2a
Len C.
Postel D.
Curr. Org. Synth.
2006,
3:
261
2b
Lin TS.
Schinazi RF.
Prusoff WH.
Biochem. Pharmacol.
1987,
36:
2713
2c
Balzarini J.
Van Aerschot A.
Herdewijn P.
De Clercq E.
Biochem. Pharmacol.
1989,
38:
869
3a
Ouma S.
Kumamoto H.
Kawato M.
Tanaka H.
Tetrahedron
2002,
58:
2497
3b
Kumamoto H.
Tanaka H.
J. Org. Chem.
2002,
67:
3541
3c
Haraguchi K.
Itoh Y.
Tanaka H.
Miyasaka T.
Tetrahedron
1993,
49:
1371
3d
Schmalz HG.
Hebler E.
Bats JW.
Durner G.
Tetrahedron Lett.
1994,
35:
4543
3e
Hebler E.
Schmalz HG.
Durner G.
Tetrahedron Lett.
1994,
35:
4547
3f
Schlawe D.
Majdalani A.
Velcicky J.
Hebler E.
Wieder T.
Prokop A.
Schmalz HG.
Angew. Chem. Int. Ed.
2004,
43:
1731
4a
Ewing DF.
Fahmi NE.
Len C.
Mackenzie G.
Ronco G.
Villa P.
Shaw G.
Nucleosides Nucleotides
1999,
18:
2613
4b
Ewing DF.
Fahmi NE.
Len C.
Mackenzie G.
Pranzo A.
J. Chem. Soc., Perkin Trans. 1
2000,
3561
4c
Belloli E.
Len C.
Mackenzie G.
Ronco G.
Bonte JP.
Vaccher C.
J. Chromatogr., A
2001,
943:
91
4d
Ewing DF.
Len C.
Mackenzie G.
Ronco G.
Villa P.
Tetrahedron: Asymmetry
2000,
11:
4995
4e
Selouane A.
Vaccher C.
Villa P.
Postel D.
Len C.
Tetrahedron: Asymmetry
2002,
13:
407
4f
Pilard S.
Riboul D.
Glacon V.
Moitessier N.
Chapleur Y.
Postel D.
Len C.
Tetrahedron: Asymmetry
2002,
13:
529
4g
Egron D.
Perigaud C.
Gosselin G.
Aubertin AM.
Faraj A.
Selouane A.
Postel D.
Len C.
Bioorg. Med. Chem. Lett.
2003,
13:
4473
5a
Nicolaou KC.
Bulger PG.
Sarlah D.
Angew. Chem. Int. Ed.
2005,
44:
4490
5b
Trnka TM.
Grubbs RH.
Acc. Chem. Res.
2001,
34:
18
6a
Poulsen CS.
Madsen R.
Synthesis
2003,
1
6b
Diver ST.
Giessert AJ.
Chem. Rev.
2004,
104:
1317
6c
Kinoshita A.
Mori M.
J. Org. Chem.
1996,
61:
8356
6d
Mori M.
Adv. Synth. Catal.
2007,
349:
121
7a
Poulsen CS.
Madsen R.
J. Org. Chem.
2002,
67:
4441
7b
Marco-Contelles J.
Arroyo N.
Ruiz-Caro J.
Synlett
2001,
652
7c
Boyer FD.
Hanna I.
Ricard L.
Org. Lett.
2001,
3:
3095
7d
Leeuwenburgh MA.
Appeldoorn CCM.
van Hooft PAV.
Overkleeft HS.
van der Marel GA.
van Boom JH.
Eur. J. Org. Chem.
2000,
873
7e
Clark JS.
Hamelin O.
Angew. Chem. Int. Ed.
2000,
39:
372
7f
Leeuwenburgh MA.
Kulker C.
Duynstee HI.
Overkleeft HS.
van der Marel GA.
van Boom JH.
Tetrahedron
1999,
55:
8253
7g
Dohlem F.
Lievre C.
Demailly G.
Eur. J. Org. Chem.
2003,
2336
8
Mori M.
Sakakira N.
Kinoshita A.
J. Org. Chem.
1998,
63:
6082
9a
Kinoshita A.
Sakakibara N.
Mori M.
J. Am. Chem. Soc.
1997,
119:
12388
9b
Kinoshita A.
Sakakibara N.
Mori M.
Tetrahedron
1999,
8155
9c
Smulik JA.
Diver ST.
J. Org. Chem.
2000,
65:
1788
9d
Mori M.
Tonogaki K.
Nishiguchi N.
J. Org. Chem.
2002,
67:
224
10
Lloyd-Jones GC.
Margue RG.
de Vries JG.
Angew. Chem. Int. Ed.
2005,
44:
7442
11
Fürstner A.
Langemann K.
J. Am. Chem. Soc.
1997,
119:
9130
12
RCEYM Reaction of
rac
-15 and
rac
-16 - Typical Procedure
The ruthenium catalyst 5 (3% mol) was dissolved in CH2Cl2 (26 mL) and ethylene gas was passed through the solution for 20 min. The enyne mixture of rac-15 and rac-16 (400 mg, 0.98 mmol) in CH2Cl2 (12 mL) was then added and the mixture was stirred under ethylene at 20 °C during 5 d. The volatiles were eliminated under reduced pressure and the residue was purified by flash chromatography (5% EtOAc in hexane) to give rac-cis-22 (100 mg, 25%) and rac-trans-22 (100 mg, 25%) in order of fractions eluted.
13a
Hansen EC.
Lee D.
J. Am. Chem. Soc.
2003,
125:
9582
13b
Hansen EC.
Lee D.
J. Am. Chem. Soc.
2004,
126:
15074
14 Selected physico-chemical data for compound cis-12: R
f
= 0.50 (5% EtOAc-hexane). 1H NMR (300 MHz, CDCl3): δ = 7.71 (m, 4 H, Ph), 7.45 (m, 6 H, Ph), 6.48 (dd, 1 H, J = 12, 18 Hz, =CH), 6.18 (s, 1 H, H3), 5.87 (s, 1 H, H5), 5.46 (d, 1 H, J = 18 Hz, =CH), 5.23 (d, 1 H, J = 12 Hz, =CH), 4.80 (m, 1 H, J = 1 Hz, H2), 3.68 (m, 4 H, OCH
2CH3, CH2OSi), 1.23 (t, 3 H, J = 8 Hz, CH3), 1.06 (s, 9 H, 3 CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 138.9 (C4), 136.0 (Ph), 135.9 (Ph), 133.9 (C3), 133.8 (Ph), 130.4 (=CH), 128.1 (Ph), 118.0 (=CH2), 107.6 (C5), 85.7 (C2), 67.6 (CH2OSi), 62.6 (OCH2), 27.2 (CH3 of t-Bu), 19.6 (Cq of t-Bu), 15.8 (CH3) ppm. ESI-HRMS: m/z calcd [M + Na+]: 431.2018; found: 431.2034.
15 Selected physico-chemical data for compound trans-12: R
f
= 0.20 (5% MeOH-CH2Cl2). 1H NMR (300 MHz, CDCl3): δ = 7.65 (m, 4 H, Ph), 7.38 (m, 6 H, Ph), 6.43 (m, 1 H, J = 12, 18Hz, =CH), 5.98 (s, 1 H, H3), 5.96 (d, 1 H, J = 4 Hz, H5), 5.43 (d, 1 H, J = 18, =CH), 5.24 (d, 1 H, J = 12 Hz, =CH), 4.90 (m, 1 H, H2), 3.72 (m, 4 H, OCH
2CH3, CH2OSi), 1.26 (t, 3 H, J = 8 Hz, CH3), 1.04 (s, 9 H, 3 CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 138.8 (C4), 136.0 (Ph), 133.9 (Ph), 130.6 (C3), 130.0 (Ph), 129.0 (=CH), 128.1 (Ph), 118.0 (=CH2), 107.6 (C5), 85.6 (C2), 66.6 (CH2OSi), 62.1 (OCH2), 27.2 (CH3 of t-Bu), 19.6 (Cq of t-Bu), 15.8 (CH3). ESI-HRMS: m/z calcd [M + Na+]: 431.2018; found: 431.2025.
16
Barfield M.
Spear RJ.
Sternhell S.
J. Am. Chem. Soc.
1975,
97:
5160